Pancreatic cancer doesn’t discriminate, and Canada’s healthcare system shouldn’t either.

As a family, we know families from smaller provinces hit barriers at every turn, from accessing crucial tools like somatic testing to joining clinical trials that improve outcomes.

Subscribe The Heather Cutler Foundation cover image

Somatic Testing

Somatic testing is essential for pancreatic cancer patients, employing next-generation sequencing and molecular profiling to analyze tumor DNA. This precision medicine approach identifies specific mutations, enabling targeted treatments that improve patient outcomes, predict responses, and provide access to clinical trials. By personalizing treatment plans based on genetic insights, somatic testing enhances the effectiveness of care and offers new hope in the fight against pancreatic cancer.

Somatic Testing page feature image